CNS|CRO Attending SfN 2016

Posted on Nov 11, 2016 in News & Events

Drs. Daphne Gill and Amber Marriott will be in San Diego November 12th – 16th for the Society for Neuroscience conference.  If you would like to learn more about how CNS|CRO can assist with your preclinical research projects, please contact Daphne by email at dagill@cnscro.com to arrange a meeting.

Read More

CNS|CRO presents poster at NHPRS Conference 2016

Posted on Jul 6, 2016 in News & Events

Amber Marriott, Research Scientist for CNS|CRO presents poster at NHPRS Conference 2016. (Photo credit: Sina Sedighi) The 13th annual meeting and conference of the Natural Health Product Research Society of Canada took place at the University of Prince Edward Island in Charlottetown from May 17 – 20, 2016. “From idea through commercialization – filling the gap in natural products research and development” was the theme of this year’s event. The event was held in conjunction with the NeuroConX Innovation Exchange, which incorporated neurodegenerative disease sessions on the brain and pain management. The event was held for the first time in Prince Edward Island and brought together individuals from all aspects of the natural health product industry, including the scientific team of CNS|CRO. Amber Marriott, a Research Scientist with CNS|CRO, presented a poster entitled, “CNS|CRO: Predictive Animal Models for Preclinical Research.” When asked how engaging with industry benefits students, Dr. Marriott replied: “The opportunity to engage with industry gives students a better understanding of the wide variety of potential career paths that exist for them and the opportunity to make contacts that will help them as they pursue their future goals,” says Marriott. The poster generated a lot of interest among conference delegates. It highlighted the company’s well-validated and highly predictive models including Parkinson’s disease, amyotrophic lateral sclerosis (ALS), epilepsy, and schizophrenia. These models are all slowly developing and progressive, thus providing greater accuracy in replicating human disease progression. The company is also well recognized for its new model development services, allowing for a fully customizable preclinical package. The three day conference concluded with a bio-partnering event hosted by the PEI BioAlliance, which facilitated even greater dialogue between interested parties on potential future joint research and/or commercialization ventures. About CNS|CRO: A wholly-owned subsidiary of Neurodyn Life Sciences Inc., CNS|CRO is a preclinical contract research organization offering a suite of animal models of neurological disease that are slowly developing and progressive, environmentally based, highly predictive, proprietary, and customizable. (Charlottetown, PE, June 28, 2016) For more information, please contact: Daphne Gill, PhD | Director of Operations | CNS|CRO T  902.628.4389 E...

Read More

CNS|CRO presents poster at NeuroConX Conference

Posted on Aug 25, 2015 in News & Events

(Charlottetown, PE | August 25, 2015) CNS|CRO was among other world-renowned researchers who shared their research services and findings at NeuroConX 2015, an international innovation exchange conference focused on neurodegenerative disorders, from July 12-14, 2015 in Charlottetown, Prince Edward Island. Now in its fifth year, the conference is presented by the PEI BioAlliance and Neurodyn Life Sciences Inc. The 2015 theme was Proteinopathies of Neurodegenerative Disorders. Daphne Gill, CNS|CRO’s Director of Operations, presented a poster on the preclinical neurological disease services of the contract research organization, including the latest portfolio of proprietary model offerings and development. “CNS|CRO’s competence, flexibility, and cost competitiveness are widely recognized,” says Gill. “This conference was an opportune occasion to demonstrate the strength of our models for replicating the human disease condition, and for translating scientific discoveries into more successful therapies.” New for 2015 is an autism spectrum disorder (ASD) behavioural test battery, an unparalleled method for assessing socio-communicative function in rats, as well as an electrophysiology platform for assessing sensory nerve conduction in vivo. This is in addition to a portfolio of highly predictive models of Parkinson’s disease, amyotrophic lateral sclerosis (ALS), epilepsy, and schizophrenia, as well as other conventional and proprietary behavioural tests. About CNS|CRO: A wholly-owned subsidiary of Neurodyn Life Sciences Inc., CNS|CRO is a preclinical contract research organization offering a suite of animal models of neurological disease that are slowly developing and progressive, environmentally based, highly predictive, proprietary, and customizable. For more information, please contact: Daphne Gill, PhD | Director of Operations | CNS|CRO T  902.628.4389 E...

Read More